Pulsed Field Ablation in Cardiac Electrophysiology
Pulsed Field Ablation in Cardiac Electrophysiology
Pulsed Field Ablation (PFA) is a disruptive technology in cardiac electrophysiology, transitioning rapidly from an experimental concept to widespread clinical implementation. Unlike conventional radiofrequency or cryoablation, which rely on thermal energy to destroy tissue, PFA is based on electroporation. Recent 2026 consensus statements from major societies, including HRS and EHRA, highlight its comparable efficacy to thermal modalities but with paradigm-shifting advantages in procedure safety and speed. (refs)
The defining triumph of PFA is its myocardial selectivity. Fundamental biophysical driver of PFA is irreversible electroporation (IRE). When exposed to a strong electric field, the cell membrane becomes permeabilized perturbing cell homeostasis. While moderate fields allow cells to recover, the parameters used in PFA intentionally exceed this threshold, causing massive membrane damage and cell death without relying on excessive heating. Consequently, the extracellular matrix and tissue architecture are largely preserved. Healing and tissue regeneration following damage to different tissues most likely makes cardiac tissue “selectively” ablated, while “sparing” collateral critical tissues. This allows operators to effectively ablate arrhythmogenic tissue while sparing adjacent critical structures like the esophagus and phrenic nerve, virtually eliminating the catastrophic complications associated with thermal ablation. Furthermore, the ultrashort energy delivery significantly accelerates procedural times, improving efficiency in the electrophysiology lab.
Despite its transformative success, recent literature emphasizes several crucial caveats. First, significant technological heterogeneity exists; waveform parameters are often proprietary, which hinders technical standardization and dose-response modelling across different commercial platforms. Second, while heralded as non-thermal, localized high-current densities at electrode margins (the “edge effect”) can still produce micro-thermal damage or charring, underscoring the need for careful catheter design. Importantly, PFA can induce adverse effects, most notably intravascular hemolysis. High electric fields can destroy red blood cells, releasing free hemoglobin that leads to renal stress and the depletion of nitric oxide (NO). This NO depletion is a suspected contributor to coronary vasospasm associated with PFA. Finally, because PFA lesions are delivered so rapidly, experts specifically warn against the temptation of “excessive ablation,” which could exacerbate myocardial injury without providing additional clinical benefit.
While PFA promises a safer alternative to thermal ablation, continued clinical surveillance, technical standardization of waveforms, and a deeper understanding of cellular and tissue responses to electroporation and its dynamics are essential to fully optimize patient treatment outcomes. The complexity of cellular and tissue responses and the fact that high voltage, high current pulses are delivered endocardially, i.e. through the catheter in the blood pool—particularly the intricate interplay of waveform parameters like amplitude, pulse duration, polarity, and catheter design—remain a critical area of biophysical research and engineering (ref).
— Contributed by Damijan Miklavčič